RUIXIN INT'L (00724) issues a profit warning, expecting a loss of approximately HK$10 million to HK$12 million for the fiscal year 20265, a decrease of approximately 71.2% to 76.0% compared to the previous year.
Ruixin International Group (00724) announced that it is expected to incur a loss of approximately HK$10 million to HK$12 million for the year ending December 31, 2025 (2025 fiscal year), compared to a loss of approximately HK$41.7 million for the year ending December 31, 2024 (2024 fiscal year), representing a significant decrease of around 71.2% to 76.0%.
RUIXIN INT'L (00724) announced that the group is expected to incur a loss of approximately HK$10 million to HK$12 million for the financial year ending December 31, 2025 (2025 fiscal year), compared to a loss of approximately HK$41.7 million for the financial year ending December 31, 2024 (2024 fiscal year), representing a significant decrease of approximately 71.2% to 76.0%.
Based on available information, the decrease in loss for the 2025 fiscal year is mainly attributed to: (i) the recovery of the group's business operations, resulting in higher revenue and gross profit for the 2025 fiscal year compared to the 2024 fiscal year; (ii) a decrease in financial expenses related to convertible notes for the 2025 fiscal year; and (iii) a reduction in administrative expenses for the 2025 fiscal year compared to the 2024 fiscal year.
Related Articles

UCD(01599) announced its performance in 2025, achieving a net profit of RMB 536 million, a year-on-year increase of 1.52%.

CHANJET (01588) released its annual performance. The shareholders' profit attributable to the company is 81.587 million yuan, an increase of 143.81% year-on-year.

CNOOC (00883) actual controlling shareholder's plan to increase holdings of the company's shares is postponed.
UCD(01599) announced its performance in 2025, achieving a net profit of RMB 536 million, a year-on-year increase of 1.52%.

CHANJET (01588) released its annual performance. The shareholders' profit attributable to the company is 81.587 million yuan, an increase of 143.81% year-on-year.

CNOOC (00883) actual controlling shareholder's plan to increase holdings of the company's shares is postponed.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


